Abstract:INTRODUCTION Aging is characterized as a syndrome of deleterious, progressive, universal, and irreversible function changes affecting every structural and functional aspect of the organism and accompanied by a generalized increase in mortality. Although a substantial number of candidates for biomarkers of aging have been proposed, none has been validated or universally accepted. Human telomeres constitute hexameric repetitive DNA sequence nucleoprotein complexes that cap chromosome ends, regulating gene expression and modulating stress-related pathways. Telomere length (TL) shortening is observed both in cellular senescence and advanced age, leading to the investigation of TL as a biomarker for aging and a risk factor indicator for the development and progression of the most common age-related diseases. OBJECTIVE The present review underlines the connection between TL and the pathophysiology of the diseases associated with telomere attrition. METHODS We performed a structured search of the PubMed database for peer-reviewed research of the literature regarding leukocyte TL and cardiovascular diseases (CVD), more specifically stroke and heart disease, and focused on the relevant articles published during the last 5 years. We also applied Hill's criteria of causation to strengthen this association. RESULTS We analyzed the recent literature regarding TL length, stroke, and CVD. Although approximately one-third of the available studies support the connection, the results of different studies seem to be rather conflicting as a result of different study designs, divergent methods of TL determination, small study samples, and patient population heterogeneity. After applying Hill's criteria, we can observe that the literature conforms to them weakly, with chronology being the only Hill criterion of causality that probably cannot be contested. CONCLUSION The present review attempted to examine the purported relation between leukocyte TL and age-related diseases such as CVD and more specific stroke and heart disease in view of the best established, comprehensive, medical and epidemiological criteria that have characterized the focused recent relevant research. Although several recommendations have been made that may contribute significantly to the field, a call for novel technical approaches and studies is mandatory to further elucidate the possible association.

Precision Measurement of Telomere Length as a Future Guide to Improve CVD Interventions

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Abstract 504: Telomere-based Assessment of Biological Age in Patients with Advanced Vascular Disease

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target

The Importance of Telomere Shortening for Atherosclerosis and Mortality

Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients with Angiographically Intermediate Lesions

Experimental and Computational Approaches to Measure Telomere Length: Recent Advances and Future Directions

Telomere length measurement as a clinical biomarker of aging and disease

The Association of Leukocyte Telomere Length and Intermediate Coronary Lesions-a Retrospective Study.

The Association between Leucocyte Telomere Length and Survival Outcomes in Patients with Cardiovascular Disease

Leukocyte Telomere Length: A Potential Biomarker for the Prognosis of Coronary Artery Disease

Telomere length and cardiovascular disease risk

Longitudinal Association of Telomere Attrition with the Effects of Antihypertensive Treatment and Blood Pressure Lowering

Contribution of leukocyte telomere length to major cardiovascular diseases onset: phenotypic and genetic insights from a large-scale genome-wide cross-trait analysis

Shorter Leukocyte Telomere Length Is Associated with Increased Major Adverse Cardiovascular Events or Mortality in Patients with Essential Hypertension

Telomere Length as a marker of biological aging: A critical review of recent literature.

Association of telomeres length with cardiovascular risk factors and arterial stiffness

Less Than Ideal Cardiovascular Health is Associated with Shorter Leukocyte Telomere Length: the National Health and Nutrition Examination Surveys, 1999–2002

Cell-free plasma telomere length correlated with the risk of cardiovascular events using machine learning classifiers

Polygenic basis and biomedical consequences of telomere length variation

Association of shorter mean telomere length with large artery stiffness in patients with coronary heart disease